# Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression

> **NCT00300404** · PHASE3 · COMPLETED · sponsor: **Zentrum für Integrative Psychiatrie** · enrollment: 40 (—)

## Conditions studied

- Schizophrenia
- Major Depression

## Interventions

- **DRUG:** daraprim
- **DRUG:** pyrimethamine
- **DRUG:** folinic acid

## Key facts

- **NCT ID:** NCT00300404
- **Lead sponsor:** Zentrum für Integrative Psychiatrie
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 40 (—)
- **Last updated:** 2006-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00300404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00300404, "Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00300404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*